AI Multi-Horizon Analysis
Limited technical data; price near $272 modestly below recent insider buy at ~$279. Positive fundamentals provide latent support but no clear intraday catalyst.
Improving profitability, record FCF and insider net buying support mild upside bias over days to weeks, though dependent on continued defense demand and no negative newsflow.
Sustained top-line acceleration, margin expansion, declining leverage, strong cash generation and government contract visibility support constructive long-term outlook, tempered by potential lumpiness in defense spending.
Strong multi-quarter improvement in revenue, margins, FCF and balance sheet with mild insider buying, but mixed short-term technicals, lumpy defense cash flows and absence of detailed price/volume data keep overall conviction neutral.
Detailed AI Fundamental Analysis
Business Snapshot
L3Harris Technologies, Inc. (LHX) is a major US defense contractor focused on search, detection, navigation, guidance, and aeronautical systems. The company designs and manufactures advanced communication, intelligence, surveillance, reconnaissance, and avionics technologies primarily for government and military customers. With approximately 45,000 employees and a market capitalization of $48.4 billion, LHX operates as a common-stock issuer listed on the NYSE since 1955. Its business is characterized by long-cycle government contracts that drive relatively stable but lumpy cash flows and consistent backlog visibility.
Financial Trends
Revenue has shown steady sequential acceleration across the last three reported quarters: $5.744B in Q1, rising to $5.881B in Q2 (+2.4% QoQ), and reaching $6.060B in Q3 (+3.0% QoQ). On a trailing basis, the latest quarterly revenue of $6.060B compares to the annualized equivalent of roughly $5.466B four periods ago, indicating clear top-line growth momentum.
Operating margins have expanded materially: 11.35% in Q1, 11.12% in Q2 (slight contraction), then a sharp improvement to 12.97% in Q3. Net margins followed a stronger upward trajectory—8.91% in Q1, 10.20% in Q2 (+129bp QoQ), and 10.43% in Q3 (+23bp QoQ)—more than doubling from the 7.35% net margin reported in the year-earlier equivalent period.
Free cash flow has been highly variable but shows strong recovery: negative $194M in Q1, improving to +$577M in Q2, then surging to +$1.837B in Q3. Compared with the $2.682B FCF reported four periods ago (full-year equivalent), the latest quarterly print annualizes to well above prior levels when adjusted for seasonality.
Balance-sheet strength continues to improve. Total assets grew from $41.195B four periods ago to $43.806B latest (+6.3% over the span). Shareholders’ equity rose steadily from $19.635B to $20.240B. Long-term debt declined from $10.443B to $9.181B, driving the Debt/Equity ratio down from 0.53 to 0.45. Cash & equivalents increased dramatically from $1.069B to $2.471B, while working capital expanded from $1.367B to $1.732B.
Financial Health
The latest quarter (ended 2026-10-02) reflects robust financial health supported by multi-quarter positive trends. Current ratio stands at a comfortable 1.20, up from a low of 1.03 earlier in the year, while working capital of $1.732B provides solid liquidity. Operating and net margins reached their highest levels in the four-period series, and the $1.837B quarterly FCF print is the strongest in the window. Debt reduction and equity growth have lowered leverage, and the cash balance more than doubled from the prior quarter. Overall, LHX demonstrates improving profitability, strong cash generation, and a fortified balance sheet heading into the end of 2026.
Insider Activity
Insider sentiment over the most recent reporting window (2026-08-11 to 2026-11-09) is Neutral with 10 signals. There were 9 buy transactions totaling $235k and zero sells, producing net buying of $235k. The sole disclosed Form 4 transaction in the latest period was an open-market purchase by Fields Kimberly A on 2026-11-02 of 394 shares at $278.96 for approximately $109.9k. The absence of selling and consistent small purchases suggest mild confidence from insiders at current price levels.
Multi-Timeframe Technical Context
With the active timeframe labeled “fundamental” and no explicit candle or indicator data supplied for 1m through daily resolutions, technical context is limited. Price action must be interpreted relative to the most recent disclosed transaction price near $279 and the current quote of $272.22. The stock is trading modestly below the insider buy level. Absent volume, moving-average, or momentum data, short-term directionality cannot be precisely quantified; however, the fundamental uptrend in earnings, margins, and cash flow provides underlying support across hourly-to-daily and weekly-to-monthly horizons.
Bull / Bear Cases
Short-term Bull Case (hours to days): Continued positive FCF momentum and the latest insider purchase could catalyze a relief rally above $272 toward the $279 level where the most recent buy occurred. Margin expansion and cash-build may encourage near-term momentum buyers if defense-sector sentiment remains constructive.
Short-term Bear Case (hours to days): Without clear technical catalysts and given the lack of real-time candle data, any negative newsflow around federal budgeting or contract delays could pressure the stock back toward recent swing lows, especially if broader market risk appetite fades.
Long-term Bull Case (weeks to months): Sustained revenue acceleration, expanding margins, record quarterly FCF, declining leverage, and rising equity position LHX for multiple expansion. Continued government demand for defense electronics should support further earnings growth and potential dividend or buyback increases.
Long-term Bear Case (weeks to months): If sequential revenue growth decelerates or if large contract wins fail to materialize, the lumpy nature of defense cash flows could reassert itself, pressuring FCF and margins. Any resurgence in long-term debt or erosion of the current 1.20x current ratio would also undermine the improving balance-sheet trend.
Key Levels & Triggers
- Immediate Support: $272.22 (current quote); potential downside trigger below this level if volume accelerates on negative news.
- Near-term Resistance: $278.96–$279 (recent insider buy price); clear break and hold above this level would confirm short-term bullish technical shift.
- Fundamental Triggers: Next quarterly revenue above $6.1B or sustained operating margin >13% would reinforce the bullish trend; FCF above $1.8B quarterly would further validate cash-flow strength.
- Balance-Sheet Triggers: Debt/Equity falling below 0.45 or cash balance exceeding $2.5B would signal additional balance-sheet improvement.
- Risk Trigger: Any reversal to negative FCF or current ratio dropping below 1.10 would shift the fundamental health assessment materially lower.